| 19-Jan-2008 | S | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 18, 2008, inter alia, has considered the following:
1. Split of Shares: the Face Value of Rs 10/- each will be sub divided in to face value of Rs 1/- each.
Bliss GVS Pharma Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on February 18, 2008, inter alia, have accorded the following:
1. Approved - Split Of Shares: The Face Value of Rs 10/- each will be sub divided in to face value of Rs 1/_ each.
(As per BSE Announcement Website dated on 18/02/2008)
SUB. :- Sub Division of equity shares of Bliss GVS Pharma Limited (Scrip Code 506197)
Trading members of the Exchange are hereby informed that, Bliss GVS Pharma Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
COMPANY NAME CODE
Bliss GVS Pharma Limited
506197
RECORD DATE
18/03/2008
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TEN equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
11/03/2008 DR-241/2007 - 2008
The auction in the equity shares of Bliss GVS Pharma Limited in Dematerialised Securities - Rolling Settlement Segment on 11/03/2008, 12/03/2008 and 13/03/2008 will be conducted as per face value of Rs.10/- each. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be No Delivery from 11/03/2008 (DR-241/2007-2008) to 17/03/2008 (DR-245/2007-2008).
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re.1/- paid up w.e.f. 11/03/2008.
ii. ISIN No. INE416D01014 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 11/03/2008, except for the auction transactions, which will be conducted on 11/03/2008, 12/03/2008 and 13/03/2008 respectively.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 26.02.2008) | 18-Mar-2008 | |
| 11-May-2023 | D | Recommended Final Dividend of 50% i.e. 0.50 paisa per equity share having face value of Rs.1/- each for the financial year ended March 31, 2023, subject to approval of the shareholders in the forthcoming 38th Annual General Meeting of the Company ('38th AGM') | 12-Jul-2023 | |
| 02-May-2022 | D | Outcome Of Board Meeting Held On Saturday, April 30, 2022
Recommended Final dividend of 50% i.e. 0.50 paisa per equity share having face value of Rs.1/-each for the financial year ended March 31, 2022.
Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') and in continuation to our intimated details on April 30, 2022 relating to Book Closure, please note that Bliss GVS Pharma Limited ('the Company') has fixed Tuesday, June 21, 2022 as the Record Date for determining entitlement of members to Final Dividend for the financial year ended on March 31, 2022. Payment of Dividend, subject to approval of the members at the ensuing AGM, will be made on or after Wednesday, June 29, 2022.
(As Per BSE Announcement Dated on 06.06.2022)
| 20-Jun-2022 | |
| 11-May-2021 | D | Recommended Final dividend of 50% i.e. 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2021, subject to approval of the shareholders in the forthcoming Annual General Meeting of the Company.
Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') and in continuation to our intimated details on July 31, 2021 relating to Book Closure, please note that Bliss GVS Pharma Limited ('the Company') has fixed Tuesday, September 14, 2021 as the Record Date for determining entitlement of members to Final Dividend for the financial year ended on March 31, 2021. Payment of Dividend, subject to approval of the members at the ensuing AGM, will be made on or after Wednesday, September 22, 2021.
(As Per BSE Announcement Dated on 30.08.2021)
| 13-Sep-2021 | |
| 16-Jun-2020 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 16, 2020, inter alia, has recommended a dividend of 50% i.e. 0.50 paisa per equity share on face value of Re. 1/- each for the financial year ended March 31, 2020, subject to approval of the shareholders in the forthcoming Annual General Meeting (ACM) of the Company. | 17-Sep-2020 | |
| 19-May-2019 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 18, 2019, inter alia, has recommended a dividend of Re. 1/- per equity share of face value of Rs. 10/- each for the financial year ended March 31, 2019, subject to approval of the shareholders in the ensuing Annual General Meeting (AGM) of the Company.
With reference to the Outcome of Board Meeting submitted to your stock exchanges on Saturday, May 18, 2019, we wish to inform you that in point no. 3 & 4 of the said outcome, we have made a minor typographical errors with regard to face value of the Company which was wrongly mentioned as Rs. 10/- and holding year of Annual General Meeting of the Company which was erroneously mentioned as 33rd Annual General Meeting. The Corrected sentence is:-
3. Recommended a dividend of Re. 1/- per equity share of face value of Re. 1/- each for the financial year ended March 31, 2019, subject to approval of the shareholders in the ensuing Annual General Meeting (AGM) of the Company.
(As Per BSE Announcement Dated 20.05.2019) | 12-Sep-2019 | |
| 17-May-2018 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 17, 2018, inter alia, has considered and approved the following:
1. Declared Final dividend at the rate of 100% i.e. Rs. 1.00 per share. | 14-Aug-2018 | |
| 17-May-2017 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2017, inter alia, has declared Final Dividend at the rate of 60% i.e. Re.0.60 per share. | 18-Sep-2017 | |
| 25-May-2016 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2016 at 3.30 p.m. inter alia, has considered and approved the following:
1. Declared Final dividend at the rate of 50% i.e. Re. 0.50 per share. | 06-Sep-2016 | |
| 30-May-2015 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2015, inter alia, has considered and approved the followings:
1. Declared Final Dividend at the rate of 50% i.e. Re. 0.50 per share. | 08-Sep-2015 | |
| 13-Feb-2015 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 12, 2015, inter alia, has considered and approved Interim Dividend @ 20% i.e. Re. 0.20 per share of face value of Re. 1 each. | 24-Feb-2015 | |
| 28-May-2014 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2014, inter alia, has recommended a Final Dividend of 50% i.e. Rs. 0.50/- per Equity Share for the year ended March 31, 2014.
(As Per BSE Announcement Dated on 28.05.2013) | 13-Aug-2014 | |
| 28-May-2013 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2013, inter alia, has recommended a dividend of 40% i.e. 0.40 per Equity Share of the year ended March 31, 2013. | 01-Aug-2013 | |
| 13-Feb-2013 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 13, 2013, inter alia, has declared an Interim Dividend of 30% i.e. Re. 0.30 per equity share for the year 2012-2013. | 25-Feb-2013 | |
| 30-May-2012 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, inter alia, has approved the following;
- Recommendation of 40% Dividend i.e. Rs. 0.40 per equity share for the year ended March 31, 2012. | 02-Aug-2012 | |
| 12-Nov-2011 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 11, 2011, inter alia, has declared 35% Interim Dividend. | 24-Nov-2011 | |
| 31-May-2011 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2011, inter alia, approved:
1. Recommendation of 30% Dividend i.e. Rs. 0.30 per equity share for the year ended March 31, 2011. | 14-Jul-2011 | |
| 11-Nov-2010 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on November 11, 2010, inter alia, approved;
1. The Board declare 30% Interim Dividend.
Sub : Record Date of Bliss GVS Pharma Ltd. (scrip code:506197)
Trading Members of the Exchange are requested to note that in the Daily Bulletin No. 216/2010 dated 12/11/2010 in the Book Closure/Record Date column, the Record Date of the captioned company has been erroneously mentioned as 25/11/2010 instead of 27/11/2010
The correct details are as under:
506197 Bliss GVS Pharma Limited RD 27/11/2010 Equity Rs.0.30 per share (30%) Interim Dividend
The correct Ex-date for Interim Dividend will be 25/11/2010 (DR-169/2010-2011) and not 24/11/2010 (DR-168/2010-2011) as mentioned in the aforesaid Daily Bulletin.
(As Per BSE Notice Dated on 12.11.2010) | 25-Nov-2010 | |
| 30-May-2010 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2010, inter alia, has approved the following:
1. Recommendation of 50% Dividend i.e. Rs. 0.50 per equity share for the year ended March 31, 2010. | 22-Jul-2010 | |
| 26-Jun-2009 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 26, 2009, inter alia, approved the following :
Recommendation of 15% Dividend for the year ended March 31, 2009. | 13-Aug-2009 | |
| 28-Apr-2008 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on April 28, 2008, inter alia, has declared 10% Interim Dividend. | 14-May-2008 | |
| 02-Aug-2007 | D | Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 31, 2007, inter alia, has transacted the following:
1. Recommendation of 10% Dividend for the year ended March 31,, 2007. | 13-Sep-2007 | |
| 15-Sep-2008 | B | SUB. :- Bonus issue of Bliss GVS Pharma Ltd. (Scrip Code 506197)
Trading Members of the Exchange are hereby informed that, Bliss GVS Pharma Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company should be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME CODE
Bliss GVS Pharma Ltd.
(506197)
RECORD DATE
30/09/2008
PURPOSE
THREE fully paid up Bonus equity shares for every FIVE existing equity shares held.
TRANSACTIONS IN EQUITY SHARES ON
Cum-Bonus basis up to Date & Sett. No.
25/09/2008 DR-124/2008- 2009
Ex-Bonus basis from Date & Sett. No.
26/09/2008 DR-125/2008-2009
Trading Members of the Exchange are requested to take note of it. | 30-Sep-2008 | 3:5 |
| 22-Sep-2005 | B | Trading Members of the Exchange are hereby informed that, Bliss Chemicals and Pharmaceuticals India Limited has fixed the Record Date for Bonus Issue. The transactions in the equity shares of the company should be done on an ex-bonus basis with effect from the undermentioned date.
RECORD DATE 01/10/2005
TWO Bonus equity share of Rs.10/- each for every FIVE existing equity shares of Rs.10/- each held. | 01-Oct-2005 | 2:5 |
| 25-Apr-2024 | BC | BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 inter alia to consider and approve
a) To consider and approve the Audited | 02-May-2024 | |
| 15-Feb-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Friday | 16-Feb-2024 | |
| 16-Feb-2024 | BC | The Board of Directors of the Company has approved an internal restruturing of foreign subsidiaries of the Company. | 16-Feb-2024 | |
| 16-Jan-2024 | BC | BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated | 23-Jan-2024 | |
| 03-Jan-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd | 04-Jan-2024 | |